Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

St. John's Wort in Relieving Hot Flashes in Postmenopausal Women With Non-Metastatic Breast Cancer

ClinicalTrials.gov ID: NCT00110136

Public ClinicalTrials.gov record NCT00110136. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 8:48 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Study of St. John's Wort for the Treatment of Hot Flashes in Women With a History of Breast Cancer

Study identification

NCT ID
NCT00110136
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Wake Forest University Health Sciences
Other
Enrollment
9 participants

Conditions and interventions

Interventions

  • St. John's Wort Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 15, 2006
Primary completion
Mar 31, 2008
Completion
Mar 31, 2008
Last update posted
Sep 28, 2021

2006 – 2008

United States locations

U.S. sites
19
U.S. states
11
U.S. cities
19
Facility City State ZIP Site status
Helen F. Graham Cancer Center at Christiana Hospital Newark Delaware 19713
MBCCOP - Howard University Cancer Center Washington D.C. District of Columbia 20060
University of Miami Sylvester Comprehensive Cancer Center - Miami Miami Florida 33136
CCOP - Central Illinois Decatur Illinois 62526
CCOP - Northern Indiana CR Consortium South Bend Indiana 46601
Feist-Weiller Cancer Center at Louisiana State University Health Sciences Shreveport Louisiana 71130-3932
CCOP - Michigan Cancer Research Consortium Ann Arbor Michigan 48106
CCOP - Beaumont Royal Oak Michigan 48073-6769
CCOP - Metro-Minnesota Saint Louis Park Minnesota 55416
Cancer Research for the Ozarks Springfield Missouri 65804
CCOP - St. Louis-Cape Girardeau St Louis Missouri 63141
Alamance Cancer Center at Alamance Regional Medical Center Burlington North Carolina 27216
Hugh Chatham Memorial Hospital Elkin North Carolina 28621
CCOP - Southeast Cancer Control Consortium Goldsboro North Carolina 27534-9479
Leo W. Jenkins Cancer Center at ECU Medical School Greenville North Carolina 27835-6028
Wake Forest University Comprehensive Cancer Center Winston-Salem North Carolina 27157-1096
CCOP - Greenville Greenville South Carolina 29615
South Carolina Cancer Specialists Hilton Head Island South Carolina 29925
CCOP - Upstate Carolina Spartanburg South Carolina 29303

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00110136, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 28, 2021 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00110136 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →